Jinzhou Tian

Dr. Jinzhou Tian

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2017 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
PDF file
MWMingqing Wei
Mingqing Wei
JSJing Shi
Jing Shi
TLTing Li
Ting Li
JNJingnian Ni
Jingnian Ni
XZXuekai Zhang
Xuekai Zhang
JTJinzhou Tian
Jinzhou Tian
Background/Objectives: The Trail‐Making Test ( TMT ), which is commonly used to measure executive function, consists of two components ( TMT ‐A and TMTB ). There is a lack of normative TMT data for Chinese elderly adults. This study aimed to evaluate the validity of the TMT in screening for cognitive impairment. Design: 2,294 Chinese‐speaking adults aged 50 to 85: 1,026 with normal cognition ( NC ), 462 with mild cognitive impairment ( MCI ), 108 with Alzheimer's disease ( AD ), 113 with vascular mild cognitive impairment (Va MCI ), 121 with vascular dementia (VaD), 282 with uncertain types of dementia, and 15 with mixed dementia. Receiver operating characteristic curve analysis was performed to test the ability of TMT scores to differentiate between NC and cognitive impairment. Results: Age, education, and sex were significantly associated with TMT completion time. The TMT ‐A exhibited sensitivity of 77.8% and specificity of 92.0% with cut‐off value of 98.5 seconds for discriminating AD from NC . The TMT ‐B had sensitivity of 83.3% and specificity of 91.8% with a cut‐off value of 188.5 seconds for discriminating AD from NC . The TMT ‐A had sensitivity of 85.7% and specificity of 81.6% for discriminating NC from VaD with a cut‐off value of 77.5 seconds, and the TMT ‐s had sensitivity of 81.6% and specificity of 83.9% with a cut‐off value of 147.5 seconds. The TMT had less sensitivity distinguishing MCI from NC . Conclusion: The Chinese version of the TMT is reliable for detecting AD or VaD but poor at distinguishing MCI from NC .

23 November 2013 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
PWPengwen Wang
Pengwen Wang
CSCaixin Su
Caixin Su
RLRuisheng Li
Ruisheng Li
HWHong Wang
Hong Wang
YRYing Ren
Ying Ren
SJShucui Jiang
Shucui Jiang

7 November 2012 in BMC Neurology
Verified
Journal Article
Open access
PDF file
JSJing Shi
Jing Shi
JTJinzhou Tian
Jinzhou Tian
MWMingqing Wei
Mingqing Wei
YMYingchun Miao
Yingchun Miao
YWYongyan Wang
Yongyan Wang
Background: The Hopkins Verbal Learning Test (HVLT) has been validated for detecting dementia in English-speaking populations. However, no studies have examined the Chinese version of the HVLT scale, and appropriate cut-off scores for dementia in the Chinese population remain unclear. Methods: 631 subjects aged 60 and over were recruited at a memory clinic at Dongzhimen Hospital in Beijing. Of these, 249 were classified as exhibiting normal cognition (NC), 134 were diagnosed with mild cognitive impairment (MCI), 97 were diagnosed with Alzheimer’s disease (AD), 14 met the diagnosis for vascular dementia (VaD), and 50 were diagnosed with other types of dementia, including mixed dementia. The discriminative capacity of the HVLT total learning score, recognition score and total score were calculated to determine their sensitivity and specificity for detecting MCI, AD and other dementias, and various cut-off scores. Results: HVLT scores were affected by age, education and sex. The HVLT total learning score exhibited an optimal balance between sensitivity and specificity using a cut-off score of 15.5 for distinguishing AD and other types of dementia from NC using the ROC curve, with sensitivity of 94.7% for distinguishing AD and all types of dementia, and specificity of 92.5% for detecting AD and 93.4% for detecting all types of dementias. We stratified the AD and MCI groups by age, and calculated the validity in each age group. In the 50–64 years age group, when the cutoff score was 18.5, the sensitivity of 0.955 and specificity of 0.921 were obtained for discriminating the NC and AD groups, and in the 65–80 years group, and optimal sensitivity and specificity values (0.948 and 0.925, respectively) were obtained with a cutoff score of 14.5. When the cutoff score was 21.5 in HVLT total recall, an optimal balance was obtained between sensitivity and specificity (69.1% and 70.7%, respectively) in distinguishing MCI from NC. Conclusion: A cut-off score of 15.5 in the HVLT total learning score led to high discriminative capacity between the dementia and NC groups. This suggests that the HVLT total learning score can provide a useful tool for discriminating dementia, but not MCI, from NC in clinical and epidemiological practice.

22 October 2010 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
JTJinzhou Tian
Jinzhou Tian
JSJing Shi
Jing Shi
XZXuekai Zhang
Xuekai Zhang
YWYongyan Wang
Yongyan Wang
It has been a clinical challenge to treat Alzheimer's disease (AD). In the present commentary we discuss whether herbal therapy could be a novel treatment method for AD on the basis of results from clinical trials, and discuss the implications for potential therapy for AD pathophysiology. There is evidence to suggest that single herbs or herbal formulations may offer certain complementary cognitive benefits to the approved drugs. The current evidence supporting their use alone, however, is inconclusive or inadequate owing to many methodological limitations. Herbal mixtures may have advantages with multiple target regulation compared with the single-target antagonist in the view of traditional Chinese medicine. Several clinical trials using herbal mixtures are being conducted in China and will hopefully show promising results for treating AD in the near future.

26 January 2017 in International Journal of Immunopathology and Pharmacology
Verified
Journal Article
Open access
PWPengwen Wang
Pengwen Wang
CSCaixin Su
Caixin Su
HFHuili Feng
Huili Feng
XCXiaopei Chen
Xiaopei Chen
YDYunfang Dong
Yunfang Dong
SJShucui Jiang
Shucui Jiang
Recent studies have shown the therapeutic potential of curcumin in Alzheimer’s disease (AD). In 2014, our lab found that curcumin reduced Aβ40, Aβ42 and Aβ-derived diffusible ligands in the mouse hippocampus, and improved learning and memory. However, the mechanisms underlying this biological effect are only partially known. There is considerable evidence in brain metabolism studies indicating that AD might be a brain-specific type of diabetes with progressive impairment of glucose utilisation and insulin signalling. We hypothesised that curcumin might target both the glucose metabolism and insulin signalling pathways. In this study, we monitored brain glucose metabolism in living APPswe/PS1dE9 double transgenic mice using a micro-positron emission tomography (PET) technique. The study showed an improvement in cerebral glucose uptake in AD mice. For a more in-depth study, we used immunohistochemical (IHC) staining and western blot techniques to examine key factors in both glucose metabolism and brain insulin signalling pathways. The results showed that curcumin ameliorated the defective insulin signalling pathway by upregulating insulin-like growth factor (IGF)-1R, IRS-2, PI3K, p-PI3K, Akt and p-Akt protein expression while downregulating IR and IRS-1. Our study found that curcumin improved spatial learning and memory, at least in part, by increasing glucose metabolism and ameliorating the impaired insulin signalling pathways in the brain.

8 December 2022 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
SLSiwei Long
Siwei Long
YCYajing Chen
Yajing Chen
YMYi Meng
Yi Meng
ZYZhizhong Yang
Zhizhong Yang
MWMingqing Wei
Mingqing Wei
JTJinzhou Tian
Jinzhou Tian